CN101879259B - Traditional Chinese medicine for treating pulmonary heart diseases - Google Patents
Traditional Chinese medicine for treating pulmonary heart diseases Download PDFInfo
- Publication number
- CN101879259B CN101879259B CN2009102354917A CN200910235491A CN101879259B CN 101879259 B CN101879259 B CN 101879259B CN 2009102354917 A CN2009102354917 A CN 2009102354917A CN 200910235491 A CN200910235491 A CN 200910235491A CN 101879259 B CN101879259 B CN 101879259B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- parts
- traditional chinese
- fine powder
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 25
- 208000004186 Pulmonary Heart Disease Diseases 0.000 title claims abstract description 10
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 11
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 11
- 241000222336 Ganoderma Species 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 239000000843 powder Substances 0.000 claims description 17
- 239000002775 capsule Substances 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 9
- 201000006306 Cor pulmonale Diseases 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 7
- 210000004369 blood Anatomy 0.000 abstract description 7
- 238000005728 strengthening Methods 0.000 abstract description 4
- 208000006673 asthma Diseases 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 208000023504 respiratory system disease Diseases 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 235000017965 Asarum canadense Nutrition 0.000 abstract 1
- 235000000385 Costus speciosus Nutrition 0.000 abstract 1
- 241000218671 Ephedra Species 0.000 abstract 1
- 241001522129 Pinellia Species 0.000 abstract 1
- 206010036790 Productive cough Diseases 0.000 abstract 1
- 241000606265 Valeriana jatamansi Species 0.000 abstract 1
- 235000014687 Zingiber zerumbet Nutrition 0.000 abstract 1
- 210000003802 sputum Anatomy 0.000 abstract 1
- 208000024794 sputum Diseases 0.000 abstract 1
- 230000001502 supplementing effect Effects 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 5
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010040007 Sense of oppression Diseases 0.000 description 3
- 241000207961 Sesamum Species 0.000 description 3
- 235000003434 Sesamum indicum Nutrition 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- AXONCVPTTFHNOI-UHFFFAOYSA-N kairine Chemical compound C1=CC(O)=C2N(C)CCCC2=C1 AXONCVPTTFHNOI-UHFFFAOYSA-N 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 210000000088 lip Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating pulmonary heart diseases, and belongs to the field of traditional Chinese medicines for treating respiratory diseases. The traditional Chinese medicine aims to have good effect and quick response. The traditional Chinese medicine is prepared from ephedra, rehmanniae praeparatum, glossy ganoderma, pinellia tuber, Chinese angelica, manchurian wildginger, fructus citri immaturus exsiccatus, notoginseng root and the like serving as raw materials, has the effects of strengthening body resistance and archaeus, supplementing qi and nourishing blood, promoting blood circulation by removing blood stasis and resolving sputum and relieving asthma, and has the advantages of obvious effect, definite curative effect and quick response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment respiratory disease.
Background technology
The existing Chinese medicine aspect that is used for the treatment of pulmonary heart disease, the deficiency that has two aspects: the one, therapeutic effect is obvious inadequately, the 2nd, it is slower to take effect, so that large quantities of patients with cor pulmonale are subsisted in uncomfortable in chest, cardiopalmus, dyspnea for a long time, edema of lower limbs, cough is breathed hard, and can not alleviate for many years, and patient and family members thereof are dissatisfied to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of pulmonary heart disease, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of pulmonary heart disease adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Herba Ephedrae 4-30 part Radix Rehmanniae 4-30 part Ganoderma 2-15 part
Rhizoma Pinelliae 4-30 part Radix Angelicae Sinensis 4-30 part Herba Asari 2-15 part
Fructus Aurantii 4-30 part Radix Notoginseng 3-25 part
The emophysematous Chinese medicine of this treatment is made by following method:
(1) by above-mentioned weight ratio, Herba Ephedrae, the Radix Rehmanniae, the Rhizoma Pinelliae, Radix Angelicae Sinensis, Herba Asari, Fructus Aurantii are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Radix Rehmanniae benefiting QI and nourishing blood in the side, the reinforcing the heart of calming the nerves, the body resistance strengthening and constitution consolidating; Close with Herba Ephedrae, Herba Asari warming lung for dispelling cold, depressed lung-energy dispersing; Be aided with Rhizoma Pinelliae drying dampness to eliminate phlegm; The Fructus Aurantii activating QI to eliminate phlegm is relievingd asthma; Radix Angelicae Sinensis, pseudo-ginseng blood-circulation-invigovating blood stasis dispersing and deswelling.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, the merit of resolving phlegm and relieving asthma, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
The Herba Ephedrae 80 gram Radix Rehmanniae 80 kairine sesames 40 grams
The Rhizoma Pinelliae 80 gram Radix Angelicae Sinensis 80 gram Herba Asaris 40 grams
Fructus Aurantii 80 gram Radix Notoginseng 60 grams
Weight in accordance with regulations, with conventional water extraction process Herba Ephedrae, the Radix Rehmanniae, the Rhizoma Pinelliae, Radix Angelicae Sinensis, Herba Asari, Fructus Aurantii are extracted, make extractum fine powder 132 grams, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 828 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
The Herba Ephedrae 150 gram Radix Rehmanniae 180 kairine sesames 80 grams
The Rhizoma Pinelliae 150 gram Radix Angelicae Sinensis 180 gram Herba Asaris 90 grams
Fructus Aurantii 150 gram Radix Notoginseng 120 grams
By above-mentioned same method, make 1678 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
The Herba Ephedrae 300 gram Radix Rehmanniae 300 kairine sesames 150 grams
The Rhizoma Pinelliae 300 gram Radix Angelicae Sinensis 300 gram Herba Asaris 150 grams
Fructus Aurantii 300 gram Radix Notoginseng 250 grams
By above-mentioned same method, make 3196 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
3 parts of 6 portions of Ganodermas of 6 parts of Radix Rehmanniae of Herba Ephedrae
3 parts of 6 parts of Herba Asaris of 6 parts of Radix Angelicae Sinensis of the Rhizoma Pinelliae
4 parts of 6 portions of Radix Notoginseng of Fructus Aurantii
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
12 parts of 25 portions of Ganodermas of 20 parts of Radix Rehmanniae of Herba Ephedrae
12 parts of 25 parts of Herba Asaris of 20 parts of Radix Angelicae Sinensis of the Rhizoma Pinelliae
18 parts of 20 portions of Radix Notoginseng of Fructus Aurantii
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science pulmonary heart disease, through 9 routine clinical observations.Selecting the tcm diagnosis pulmonary heart disease is standard: have a delicate constitution, and limb adynamia, feeling of oppression and pain in the chest, cough is breathed hard, dyspnea, edema of lower limbs.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 6 examples, women's 3 examples do not have other serious disease, and the age is 57 years old-79 years old, 67.2 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, and on one's body energetically, symptoms such as feeling of oppression and pain in the chest, dyspnea are obviously alleviated.
2, effective: body constitution strengthens, and symptoms such as feeling of oppression and pain in the chest, dyspnea are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 3 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 3 months after, symptom is obviously improved.9 philtrums of clinical experiment, produce effects 4 people, effective 4 people, invalid 1 people, total effective rate 88.8%.
Claims (1)
1. a Chinese medicine for the treatment of pulmonary heart disease is characterized in that, described Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Herba Ephedrae 4---15 parts in 30 parts of Radix Rehmanniae 4---30 portions of Ganodermas 2---
The Rhizoma Pinelliae 4---15 parts of 30 parts of Radix Angelicae Sinensis 4---30 parts of Herba Asaris 2---
25 parts of Fructus Aurantiis 4---30 portions of Radix Notoginseng 3---
The emophysematous Chinese medicine of this treatment is made by following method:
(1) by above-mentioned weight ratio, Herba Ephedrae, the Radix Rehmanniae, the Rhizoma Pinelliae, Radix Angelicae Sinensis, Herba Asari, Fructus Aurantii are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; Make Chinese medicine granules, powder, capsule, watered pill, tablet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102354917A CN101879259B (en) | 2009-10-16 | 2009-10-16 | Traditional Chinese medicine for treating pulmonary heart diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102354917A CN101879259B (en) | 2009-10-16 | 2009-10-16 | Traditional Chinese medicine for treating pulmonary heart diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101879259A CN101879259A (en) | 2010-11-10 |
| CN101879259B true CN101879259B (en) | 2011-11-23 |
Family
ID=43051488
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102354917A Expired - Fee Related CN101879259B (en) | 2009-10-16 | 2009-10-16 | Traditional Chinese medicine for treating pulmonary heart diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101879259B (en) |
-
2009
- 2009-10-16 CN CN2009102354917A patent/CN101879259B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101879259A (en) | 2010-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101406594B (en) | Chinese medicine for treating tumor of lung | |
| CN101564505B (en) | Chinese medicament for treating pulmonary heart disease | |
| CN101850071B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843829B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101879259B (en) | Traditional Chinese medicine for treating pulmonary heart diseases | |
| CN101897847B (en) | Traditional Chinese medicine for curing asthma | |
| CN101850017B (en) | Chinese medicament for treating asthma | |
| CN101884704B (en) | Traditional Chinese medicine for treating asthma | |
| CN101884762B (en) | Traditional Chinese medicine for treating emphysema | |
| CN101850018A (en) | Chinese medicament for treating cervical spondylosis | |
| CN101850055B (en) | Chinese medicament for treating coronary heart diseases | |
| CN101874851B (en) | Traditional Chinese medicine for treating chronic infectious arthritis | |
| CN101843698B (en) | Chinese medicament for treating cervical spondylosis | |
| CN101843679B (en) | Chinese medicament for treating cervical spondylosis | |
| CN101850078B (en) | Chinese medicament for treating chronic nephritis | |
| CN101884747B (en) | Traditional Chinese medicine for treating chronic nephritis | |
| CN101843705B (en) | Chinese medicament for treating lupus erythematosus | |
| CN101843717B (en) | Chinese medicament for treating coronary disease | |
| CN101843844B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101843830B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101843797A (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101564476B (en) | Chinese medicament for treating coronary heart disease | |
| CN101850079B (en) | Chinese medicament for treating asthma | |
| CN101850083B (en) | Chinese medicament for treating asthma | |
| CN101850014B (en) | Chinese medicament for treating asthma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: WEI DEZONG Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20141218 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 541105 GUILIN, GUANGXI ZHUANG AUTONOMOUS REGION |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20141218 Address after: 541105, room 2, unit 8, 1 Xing Xing Road, 202 Town, Lingui County, the Guangxi Zhuang Autonomous Region, Lingui Patentee after: Wei Dezong Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd. |
|
| DD01 | Delivery of document by public notice |
Addressee: Wei De Zong Document name: Notification of Termination of Patent Right |
|
| DD01 | Delivery of document by public notice | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111123 Termination date: 20181016 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |